Laboratory Abnormalities in Developing Diabetic Ketoacidosis
When a patient is developing DKA, expect hyperglycemia (>250 mg/dL), metabolic acidosis (pH <7.3, bicarbonate <15-18 mEq/L), elevated anion gap (>10-12 mEq/L), positive ketones (especially β-hydroxybutyrate), and electrolyte disturbances including paradoxically elevated or normal serum potassium despite total body depletion. 1
Core Metabolic Derangements
Glucose Abnormalities
- Blood glucose >250 mg/dL is the classic threshold for DKA diagnosis, though approximately 10% of cases present as euglycemic DKA with glucose <200 mg/dL (especially with SGLT2 inhibitor use, pregnancy, reduced oral intake, or recent insulin administration) 1, 2
- Hyperglycemia drives osmotic diuresis leading to profound dehydration and hemoconcentration 1
Acid-Base Disturbances
- Venous pH <7.3 is required for diagnosis (venous pH runs approximately 0.03 units lower than arterial, making venous sampling sufficient for monitoring) 1
- Serum bicarbonate <15-18 mEq/L indicates metabolic acidosis severity 1
- Severity stratification by pH:
Anion Gap Elevation
- Calculate anion gap as [Na⁺] - ([Cl⁻] + [HCO₃⁻]), which should be >10-12 mEq/L in DKA 1
- The elevated anion gap reflects accumulation of unmeasured ketoacids (β-hydroxybutyrate, acetoacetate) 1
Ketone Body Measurements
Preferred Testing Method
- Blood β-hydroxybutyrate (β-OHB) is the gold standard for diagnosis and monitoring, as it measures the predominant and strongest ketoacid in DKA 1, 2
- Normal fasting β-OHB is <0.5 mmol/L; DKA resolution requires normalization to this level 1
Critical Pitfall to Avoid
- Never rely on urine ketone strips or nitroprusside-based tests for diagnosis or monitoring—these only detect acetoacetate and acetone, completely missing β-OHB 1, 2
- During treatment, β-OHB converts to acetoacetate, making nitroprusside tests paradoxically appear worse even as the patient improves 1
Electrolyte Abnormalities
Potassium Disturbances
- Total body potassium is depleted by 3-5 mEq/kg despite normal or elevated initial serum levels due to extracellular shift from acidosis and insulin deficiency 1
- Hyperkalemia occurs in 32.5% of DKA patients at presentation due to hemoconcentration and transcellular shifts 3
- Hypokalemia occurs in 7.5% initially but develops rapidly during treatment as insulin drives potassium intracellularly 3
- Serum potassium is negatively correlated with estimated glomerular filtration rate (eGFR) 3
Sodium Abnormalities
- Measured serum sodium is typically low due to osmotic dilution from hyperglycemia 1
- Correct sodium for hyperglycemia using: [measured Na (mEq/L)] + [glucose (mg/dL) - 100]/100 × 1.6 1
- Corrected sodium is often elevated due to free water losses from osmotic diuresis 1
Other Electrolyte Changes
- Serum phosphorus, magnesium, and calcium are generally elevated at presentation due to hemoconcentration 3
- Chloride may be elevated, contributing to a hyperchloremic component as ketoacids are cleared 1
Renal Function Markers
- Blood urea nitrogen (BUN) and creatinine are elevated reflecting prerenal azotemia from volume depletion 1
- Estimated GFR is significantly lower in DKA patients compared to diabetic controls, and is an important factor affecting serum potassium levels 3
- Renal function deteriorates significantly when DKA occurs, requiring close monitoring 3
Additional Laboratory Findings
Osmolality
- Serum osmolality is elevated and should be calculated or measured directly 1
- Effective osmolality = 2 × [Na] + [glucose]/18 contributes to altered mental status 1
Complete Blood Count
- Leukocytosis is common even without infection due to stress response 1
- Obtain complete blood count with differential to identify infection as a precipitating cause 1
Urinalysis
- Glucosuria (4+) and ketonuria (4+) are typically present 4
- Persistent glucosuria and ketonuria despite serum glucose below renal threshold can indicate ongoing ketoacidosis, especially in euglycemic DKA 4
Monitoring Frequency During Active DKA
- Check electrolytes, glucose, BUN, creatinine, osmolality, and venous pH every 2-4 hours during treatment 1
- Monitor β-hydroxybutyrate every 2-4 hours alongside other parameters, as ketone clearance lags behind glucose normalization 1
- Venous pH and anion gap adequately track acidosis resolution without requiring repeated arterial blood gases 1
Resolution Criteria
DKA is resolved only when ALL of the following are met:
- Glucose <200 mg/dL 1
- Serum bicarbonate ≥18 mEq/L 1
- Venous pH >7.3 1
- Anion gap ≤12 mEq/L 1
- β-hydroxybutyrate normalized to <0.5 mmol/L 1
Special Considerations
Mixed Acid-Base Disorders
- Approximately 23% of DKA cases present with diabetic ketoalkalosis (pH >7.4) due to concurrent metabolic alkalosis and/or respiratory alkalosis 5
- These patients still have elevated anion gap metabolic acidosis and may have severe ketoacidosis (β-OHB ≥3 mmol/L) requiring full DKA treatment despite alkalemic pH 5